Golden Triangle Pathology is categorized under Pathological Laboratories in Columbus, MS and active since 2006.
Golden Triangle Pathology was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact John Fullenwider at the company’s single location by writing to 2520 5th St North, Columbus, Mississippi MS 39705 or by phoning (662) 327-0020. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Golden Triangle Pathology |
| Contact Person: | John Fullenwider |
| Address: | 2520 5th St North, Columbus, Mississippi 39705 |
| Phone Number: | (662) 327-0020 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 6215110 |
| Share This Business: |
Golden Triangle Pathology was started in 2006 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact John Fullenwider for inquiries that concern Golden Triangle Pathology by calling the company number (662) 327-0020, as your correspondence is most welcome. Additionally, the physical location of the single location of Golden Triangle Pathology can be found at the coordinates 33.525364,-88.42898 as well as the street address 2520 5th St North in Columbus, Mississippi 39705.
For its online presence, you may visit Golden Triangle Pathology’s website at and engage with its social media outlets through on Twitter and on Facebook.